SAILIFE logo

Sai Life Sciences Limited Stock Price

NSEI:SAILIFE Community·₹266.7b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 3 Fair Values set on narratives written by author

SAILIFE Share Price Performance

₹1,257.30
463.65 (58.42%)
₹1,275.00
Fair Value
₹1,257.30
463.65 (58.42%)
1.4% undervalued intrinsic discount
₹1,275.00
Fair Value
Price ₹1,257.30
AnalystConsensusTarget ₹1,275.00

SAILIFE Community Narratives

·
Fair Value ₹1.28k 1.4% undervalued intrinsic discount

Global Supply Chain Rebalancing Will Support Long Term Demand For Indian CRDMO Capacity

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative

Trending Discussion

Updated Narratives

SAILIFE logo

SAILIFE: Board Review Of Audited Results Will Shape Measured Outlook

Fair Value: ₹1.28k 1.4% undervalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with proven track record.

1 Risk
2 Rewards

Sai Life Sciences Limited Key Details

₹21.9b

Revenue

₹5.7b

Cost of Revenue

₹16.2b

Gross Profit

₹12.7b

Other Expenses

₹3.5b

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
Aug 06, 2026
16.45
73.96%
15.91%
3.8%
View Full Analysis

About SAILIFE

Founded
1999
Employees
3401
CEO
Krishnam Kanumuri
WebsiteView website
www.sailife.com

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.